Betül Kaya Çavuşoğlu

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Molecular Docking

Top Venues

Journal of enzyme inhibition and medicinal chemistry

RSC medicinal chemistry

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Ali Savaş Koparal, Zafer Asım Kaplancıklı
Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Ulviye Acar Çevik, Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah Burak Karaduman, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık Özkan, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors. Archiv der Pharmazie 354 (3) (2020)
Begüm Nurpelin Sağlık Özkan, Betül Kaya Çavuşoğlu, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling. RSC medicinal chemistry 11 (9) (2020)